Search Results - "Moschini, Marco"

Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data Study.

Authors: Pyrgidis, Nikolaos Moschini, Marco Tzelves, Lazaros et al.

Source: Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 12, p3531. 8p.

How can we reduce morbidity after robot‐assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group.

Authors: Pellegrino, Francesco Martini, Alberto Falagario, Ugo Giovanni et al.

Source: BJU International. Jun2024, Vol. 133 Issue 6, p673-677. 5p.

Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy.

Authors: Zattoni, Fabio Mari, Andrea Falagario, Ugo Giovanni et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 9, p1310. 19p.

Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate.

Authors: Laukhtina, Ekaterina Moschini, Marco Krajewski, Wojciech et al.

Source: BJU International. May2023, Vol. 131 Issue 5, p571-580. 10p.

Embracing diversity, equity, and inclusion in academic urology: the Young Academic Urologists (YAU) perspective.

Authors: Lammers, Rianne J.M. Pietropaolo, Amelia Cacciamani, Giovanni et al.

Source: BJU International. Jan2025, Vol. 135 Issue 1, p9-12. 4p.

Long‐term functional outcomes after robot‐assisted radical cystectomy with intracorporeal ileal orthotopic neobladder.

Authors: Pellegrino, Francesco Scilipoti, Pietro Rosiello, Giuseppe et al.

Source: BJU International. Jul2024, Vol. 134 Issue 1, p48-50. 3p.

GPT-4 generates accurate and readable patient education materials aligned with current oncological guidelines: A randomized assessment.

Authors: Rodler, Severin Cei, Francesco Ganjavi, Conner et al.

Source: PLoS ONE. 6/4/2025, Vol. 20 Issue 6, p1-14. 14p.

Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer.

Authors: Longoni, Mattia Di Bello, Francesco Rodriguez Peñaranda, Natali et al.

Source: BJU International. May2025, Vol. 135 Issue 5, p828-834. 7p.

Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer.

Authors: de Angelis, Mario Siech, Carolin Di Bello, Francesco et al.

Source: BJU International. Apr2025, Vol. 135 Issue 4, p596-602. 7p.

The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer.

Authors: von Deimling, Markus Mertens, Laura S. Furrer, Marc et al.

Source: BJU International. Jul2024, Vol. 134 Issue 1, p119-127. 9p.

Trimodal therapy effect on survival in urothelial vs non‐urothelial bladder cancer.

Authors: de Angelis, Mario Baudo, Andrea Siech, Carolin et al.

Source: BJU International. Oct2024, Vol. 134 Issue 4, p602-607. 6p.

Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy.

Authors: Ben‐David, Reuben Pellegrino, Francesco Mehrazin, Reza et al.

Source: BJU International. Aug2025, Vol. 136 Issue 2, p321-328. 8p.

Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.

Authors: Pichler, Renate Stäblein, Johannes Mari, Andrea et al.

Source: Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p2031. 7p.

Long‐term functional and oncological outcomes of nerve‐sparing and prostate capsule‐sparing cystectomy: a single‐centre experience.

Authors: Saad, Mohamed Moschini, Marco Stabile, Armando et al.

Source: BJU International. Feb2020, Vol. 125 Issue 2, p253-259. 7p.

Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives.

Authors: Gabriel, Pierre-Etienne Horowitz, Amir Guerrero-Ramos, Felix et al.

Source: Cancers. Nov2025, Vol. 17 Issue 21, p3555. 13p.

Acute kidney disease after radical cystectomy for bladder cancer: a new onco‐nephrological view.

Authors: Trevisani, Francesco Floris, Matteo Longoni, Mattia et al.

Source: BJU International. Oct2025, Vol. 136 Issue 4, p625-632. 8p.

Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node‐positive bladder cancer.

Authors: von Deimling, Markus Furrer, Marc Mertens, Laura S. et al.

Source: BJU International. Mar2024, Vol. 133 Issue 3, p341-350. 10p.

Urinary function in female patients after traditional, organ‐sparing and nerve‐sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis.

Authors: Laukhtina, Ekaterina von Deimling, Markus Pradere, Benjamin et al.

Source: BJU International. Mar2024, Vol. 133 Issue 3, p246-258. 13p.

Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis.

Authors: Mori, Keiichiro Yanagisawa, Takafumi Fukuokaya, Wataru et al.

Source: International Journal of Urology. Jan2024, Vol. 31 Issue 1, p25-31. 7p.

Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy.

Authors: D'Andrea, David Soria, Francesco Moschini, Marco et al.

Source: BJU International. Sep2024, Vol. 134 Issue 3, p459-464. 6p.